Regulators reject MDMA as treatment for PTSD, calling for more study

WASHINGTON (AP) — Federal health regulators have declined to approve the psychedelic drug MDMA as a therapy for PTSD, a setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental-health conditions. Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based [...]

By |2024-08-16T10:07:44-04:00Wednesday, August 14, 2024|

Ohio State study of law enforcement personnel: Head trauma may be correlated with symptoms of PTSD, depression

A study in which Ohio State University researchers investigated the relationship between head trauma and mental-health symptoms among central Ohio law enforcement personnel revealed more instances of post-traumatic stress disorder and depression among the injured cohort. Nine percent of the 282 respondents who reported one or more head injuries screened positive for PTSD symptoms, while [...]

By |2024-08-09T13:54:17-04:00Thursday, August 8, 2024|

Amid bumper crop of wild mushrooms, Midwest sees rise in poison control calls

MINNEAPOLIS (AP) — The warm, soggy summer across much of the Midwest has produced a bumper crop of wild mushrooms — and a surge in calls to poison control centers. At the Minnesota Regional Poison Center, calls from April through July more than tripled over the same period last year, said Samantha Lee, the center's [...]

By |2024-08-01T14:04:08-04:00Wednesday, July 31, 2024|

As greenhouses become more popular, concerns about worker welfare grow

From opposite ends of the world, the uncomfortable conditions Shamim Ahamed and Purvi Tiwari experienced doing separate doctoral research inside greenhouses inspired them to study the heat in the indoor structures. Tiwari, a researcher at Indira Gandhi Agricultural University in India, realized the heat-amplifying effect of greenhouses is a big concern that should be studied [...]

By |2024-07-23T14:36:30-04:00Monday, July 22, 2024|

Drugmakers have few incentives to pursue rare disease cures

Robin Alderman faces an agonizing reality: Gene therapy might cure her son Camden's rare, inherited immune deficiency. Yet it's not available to him. In 2022, London-based Orchard Therapeutics stopped investing in an experimental treatment for the condition, Wiskott-Aldrich syndrome, and there are no gene therapy studies he can join. "We feel like we are the [...]

By |2024-07-02T12:21:58-04:00Thursday, June 27, 2024|

Drug that can slow Alzheimer’s receives support from the FDA

WASHINGTON (AP) — A closely watched Alzheimer's drug from Eli Lilly earlier this week won the backing of federal health advisers, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted unanimously that the drug's ability to slow the disease outweighs [...]

By |2024-06-14T13:12:50-04:00Thursday, June 13, 2024|

Researchers find higher levels of chemical than expected in southeast Louisiana

NEW ORLEANS (AP) — Researchers using high-tech air monitoring equipment rolled through an industrialized stretch of southeast Louisiana in mobile labs and found levels of a carcinogen in concentrations as much as 10 times higher than previously estimated, according to a paper published in the journal Environmental Science & Technology. The study by researchers at [...]

By |2024-06-14T13:13:14-04:00Thursday, June 13, 2024|
Go to Top